[Pleural mesothelioma. A case report].
Malignant mesothelioma can be considered a rare neoplasm, very aggressive, chemo- and radio-resistant, characterized by high percentage of mortality and precarious quality of life. Surgery, radio- and chemo-therapy must be administered with articulate strategy and with realistic objective of palliation. Our experience can represent a model in this direction: we treated a patient with palliative surgery and following loco-regional and "maintenance" systemic chemotherapy with taxol at minimal efficacious dosage (135 mg/m2 every 3 weeks). After 27 months the patient is alive and with a good quality of life.
Della Vittoria Scarpati
M
M
Istituto di Chirurgia Toracica, II Università, Napoli.
Parascandolo
V
V
Santini
M
M
Di Crescenzo
V G
VG
Di Lieto
E
E
Vicidomini
G
G
D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D008875:Middle Aged; D009367:Neoplasm Staging; D010166:Palliative Care; D010997:Pleural Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy
Mesotelioma pleurico. Descrizione di un caso.